Biotech news
Pharma
IP boutique KIPA has strengthened its team with the addition of Iceland-based patent attorney Thorlakur Jonsson. 6 August 2020
Americas
A former researcher at the research institute of the Nationwide Children’s Hospital in Ohio has pleaded guilty to conspiring to steal scientific trade secrets to sell in China. 3 August 2020
Americas
The development of CRISPR technology is showing no signs of losing momentum, and Arbor Biotechnologies is one company that is taking full advantage of this. We spoke to Kelly Morgan, senior director, head of IP and legal at the company to find out more. 31 July 2020
Biotech
Swiss company Roche has partnered with Belgium-based biopharmaceutical company UCB to develop an antibody treatment for people living with Alzheimer’s disease. 30 July 2020
Biotech
The University of Texas is protected from being forced to become an involuntary plaintiff in an infringement suit because of sovereign immunity, the US Court of Appeals for the Federal Circuit ruled on Friday, July 24. 28 July 2020
Pharma
Gilead Sciences is continuing its expansion into the field of cancer therapeutics with the purchase of a 49.9% stake in California-based biotechnology company Tizona. 22 July 2020
Biotech
Biotechnology company Qiagen has failed in its bid to stop diagnostics company HandyLab from retaining a patent for a diagnostic system, according to a decision issued by the US Patent Trial and Appeal Board on Tuesday, July 14. 20 July 2020
Biotech
As the UK Supreme Court reverses a Court of Appeal decision relating to sufficiency, the ruling leaves patent applicants in a potentially difficult position, argues David Fyfield of Charles Russell Speechlys. 16 July 2020
Biotech
The US International Trade Commission (USITC) will take another look at whether German orthopedics company Zimmer Biomet violated the IP rights of medical technology company Heraeus, it announced yesterday, Monday 13 July. 14 July 2020
Biotech
China’s Junshi Biosciences has licensed technology to produce an antibody against COVID-19 from Swiss biotechnology firm Lonza. 14 July 2020